Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIME: Soluble Ferric Pyrophosphate in ESRD
NCT01286012Phase 2Completed
- Sponsor
- Rockwell Medical
- Start
- Jan 2011
- Primary completion
- Jan 2013
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of ferric pyrophosphate in anemia, sponsored by Rockwell Medical. Started Jan 2011; status: completed.
02
Drugs
ferric pyrophosphate
03
Conditions
anemia
Beyond the preview
Go deeper on NCT01286012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01286012.